Integra LifeSciences Holdings Corporation
IART
$13.05
-$0.01-0.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.64B | 1.62B | 1.62B | 1.61B | 1.56B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.64B | 1.62B | 1.62B | 1.61B | 1.56B |
| Cost of Revenue | 702.95M | 693.51M | 674.49M | 656.01M | 637.00M |
| Gross Profit | 940.02M | 928.23M | 949.81M | 954.52M | 927.92M |
| SG&A Expenses | 670.48M | 668.48M | 673.13M | 668.77M | 637.03M |
| Depreciation & Amortization | 14.90M | 14.93M | 14.89M | 14.23M | 13.54M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.47B | 1.47B | 1.46B | 1.43B | 1.38B |
| Operating Income | 168.36M | 153.60M | 168.10M | 177.12M | 189.02M |
| Income Before Tax | -545.27M | -558.81M | -43.04M | -18.24M | -11.92M |
| Income Tax Expenses | -49.94M | -58.18M | -14.09M | -11.29M | -5.38M |
| Earnings from Continuing Operations | -495.34 | -500.63 | -28.96 | -6.94 | -6.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -495.34M | -500.63M | -28.96M | -6.94M | -6.54M |
| EBIT | 168.36M | 153.60M | 168.10M | 177.12M | 189.02M |
| EBITDA | 326.45M | 309.13M | 315.61M | 318.02M | 316.21M |
| EPS Basic | -6.46 | -6.53 | -0.38 | -0.09 | -0.09 |
| Normalized Basic EPS | 0.86 | 0.79 | 0.95 | 1.06 | 1.20 |
| EPS Diluted | -6.46 | -6.53 | -0.38 | -0.09 | -0.09 |
| Normalized Diluted EPS | 0.86 | 0.79 | 0.95 | 1.06 | 1.20 |
| Average Basic Shares Outstanding | 306.33M | 306.03M | 306.74M | 308.01M | 309.55M |
| Average Diluted Shares Outstanding | 306.33M | 306.03M | 306.74M | 308.01M | 309.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |